An opinion piece argues that Namibian CSOs have become trapped in donor-dependent cycles, driven by foreign funding priorities rather than local needs, and proposes reforms including a national civil society fund, government service contracting, domestic resource mobilisation, and stronger accountability to communities rather than foreign donors.
30 January 2026 · New Era →
The Ministry of Health and Social Services has approved lenacapavir, a long-acting injectable HIV preventive medicine administered twice yearly, placing Namibia among the first African countries to do so. The ministry acknowledges the drug's breakthrough potential but emphasises the need for affordable pricing to ensure equitable access across the continent, given the current global list price of over USD 28,000 per person annually.
30 January 2026 · Informanté →
Namibia has fast-tracked registration of lenacapavir, a long-acting injectable HIV prevention medication administered twice yearly, placing it among the first African countries to approve the next-generation pre-exposure prophylaxis option. However, Health Minister Esperance Luvindao highlighted that the drug's current global price of over US$28,000 per person per year is unaffordable for most Africans, and the ministry is engaging with the African Medicines Agency to advocate for price reductions.
30 January 2026 · The Namibian →